Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Reusch

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2021
Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)Evgeny Shutov, Władysław Sułowicz, Ciro Esposito, et al.
The American Journal of Dermatopathology|June 23, 2020
Twenty-Eight Cases of Extraocular Sebaceous Carcinoma: A Correlative Clinicopathological and Immunohistochemical Analysis of Extraocular Sebaceous Carcinomas and Benign Sebaceous Gland TumorsWerner Boecker, Michael Reusch, Volker Mielke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 10, 2006
[Melanocytic nevi]Axel Hauschild, Claus Garbe, Jürgen Bauer, et al.
Kidney International Reports|May 2, 2022
Two Phase 3 Studies on Ophthalmologic Effects of Roxadustat Versus DarbepoetinYasir J Sepah, Quan Dong Nguyen, Yusuke Yamaguchi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 22, 2014
Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practiceMatthias Augustin, Ulrich Mrowietz, Bernd Bonnekoh, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2017
Matthias Augustin, Ulrich Mrowietz, Bernd Bonnekoh, et al.
Transplantation Direct|November 13, 2024
Assessing Pharmacokinetics and Safety of Therapeutic Alpha-1-Microglobulin in First-in-Human Kidney Transplantation: A Noncomparative Open-Label Multiple-Dose Phase 1b StudyJohan E A Nordström, Lars M Wennberg, Greg Nowak, et al.
Advances in Therapy|February 7, 2023
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 StudiesJonathan Barratt, Frank Dellanna, Jose Portoles, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 19, 2011
Melanocytic neviAxel Hauschild, Friederike Egberts, Claus Garbe, et al.
Archives of Dermatological Research|March 28, 2009
The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseasesMatthias Augustin, Marc A Radtke, Ina Zschocke, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2021
Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)Evgeny Shutov, Władysław Sułowicz, Ciro Esposito, et al.
The American Journal of Dermatopathology|June 23, 2020
Twenty-Eight Cases of Extraocular Sebaceous Carcinoma: A Correlative Clinicopathological and Immunohistochemical Analysis of Extraocular Sebaceous Carcinomas and Benign Sebaceous Gland TumorsWerner Boecker, Michael Reusch, Volker Mielke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 10, 2006
[Melanocytic nevi]Axel Hauschild, Claus Garbe, Jürgen Bauer, et al.
Kidney International Reports|May 2, 2022
Two Phase 3 Studies on Ophthalmologic Effects of Roxadustat Versus DarbepoetinYasir J Sepah, Quan Dong Nguyen, Yusuke Yamaguchi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 22, 2014
Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practiceMatthias Augustin, Ulrich Mrowietz, Bernd Bonnekoh, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2017
Matthias Augustin, Ulrich Mrowietz, Bernd Bonnekoh, et al.
Transplantation Direct|November 13, 2024
Assessing Pharmacokinetics and Safety of Therapeutic Alpha-1-Microglobulin in First-in-Human Kidney Transplantation: A Noncomparative Open-Label Multiple-Dose Phase 1b StudyJohan E A Nordström, Lars M Wennberg, Greg Nowak, et al.
Advances in Therapy|February 7, 2023
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 StudiesJonathan Barratt, Frank Dellanna, Jose Portoles, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 19, 2011
Melanocytic neviAxel Hauschild, Friederike Egberts, Claus Garbe, et al.
Archives of Dermatological Research|March 28, 2009
The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseasesMatthias Augustin, Marc A Radtke, Ina Zschocke, et al.
Pageof 5